Pesquisas alternativas:
"caso open" » "caso lopez" (Expandir a Pesquisa), "cases open" (Expandir a Pesquisa), "cado open" (Expandir a Pesquisa), "caao open" (Expandir a Pesquisa), "caoto open" (Expandir a Pesquisa), "casdo open" (Expandir a Pesquisa), "casao open" (Expandir a Pesquisa), "caso opens" (Expandir a Pesquisa)
"do opens" » "do open" (Expandir a Pesquisa), "o opens" (Expandir a Pesquisa), "do openers" (Expandir a Pesquisa), "ddo opens" (Expandir a Pesquisa), "dao opens" (Expandir a Pesquisa), "do openss" (Expandir a Pesquisa)
"so open" » "do open" (Expandir a Pesquisa), "ao open" (Expandir a Pesquisa), "oto open" (Expandir a Pesquisa), "sdo open" (Expandir a Pesquisa), "sao open" (Expandir a Pesquisa), "so opens" (Expandir a Pesquisa)
"o open" » "do open" (Expandir a Pesquisa), "ao open" (Expandir a Pesquisa), "o opens" (Expandir a Pesquisa)
"esmo open" » "esmdo open" (Expandir a Pesquisa), "esmao open" (Expandir a Pesquisa), "esmo opens" (Expandir a Pesquisa), "esto open" (Expandir a Pesquisa), "eso open" (Expandir a Pesquisa), "ecmo open" (Expandir a Pesquisa)
A mostrar 121 - 140 resultados de 374 para a pesquisa '(((((("do opens") OR ("o open"))) OR ("esmo open"))) OR ((("so open") OR ("caso open"))))', tempo de pesquisa: 1.36seg Refinar resultados
Phase I study of neoadjuvant chemotherapy with S-1 and oxaliplatin for locally advanced gastric cancer (Neo G-SOX PI)
Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma

Recent developments and translational aspects in targeted therapy for metastatic breast cancer
KRAS-driven lung adenocarcinoma: combined DDR1/Notch inhibition as an effective therapy

ESMO gave me a chance to help make a difference: a personal reflection on the occasion of receiving the 2015 ESMO Award
CECOG educational illustrations: the blood–brain barrier and its relevance for targeted cancer therapies and immuno-oncology

Recent advances in the biology and treatment of brain metastases of non-small cell lung cancer: summary of a multidisciplinary roundtable discussion
Health-related quality of life in a randomised phase III study of gemcitabine plus S-1, S-1 alone and gemcitabine alone for locally advanced or metastatic pancreatic cancer: GEST study

Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I–II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer
S-1 and oxaliplatin (SOX) plus bevacizumab versus mFOLFOX6 plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer: updated overall survival analyses of the open-label, non-inferiority, randomised phase III: SOFT study

Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
The European Cancer Patient’s Bill of Rights, update and implementation 2016

Switching from standard to dose-dense chemotherapy in front-line treatment of advanced ovarian cancer: a retrospective study of feasibility and efficacy
Cancer and liver cirrhosis: implications on prognosis and management

Update on clinical research and state of the art management of patients with advanced sarcomas and GIST
Radiological imaging markers predicting clinical outcome in patients with metastatic colorectal carcinoma treated with regorafenib: post hoc analysis of the CORRECT phase III trial (RadioCORRECT study)

Predictive and prognostic biomarkers of targeted agents and modern immunotherapy in renal cell carcinoma
Cancer genome: highlights of a Nature Medicine perspective

Immune checkpoint blockade in small cell lung cancer: is there a light at the end of the tunnel?
Recent advances in the biology of human circulating tumour cells and metastasis

Ferramentas de pesquisa: Obter Feed RSS — Enviar pesquisa por email — Guardar a pesquisa